Page 1696 of 9001
Apple's Q1/25 results face concerns due to declining iPhone sales in China and lower chip forecasts from TSMC, impacting stock performance. Learn more on AAPL stock here...
Continue Reading
Explore high-yield investing opportunities under the Trump administration for potential growth and attractive yields in the next four years. Read what investors need to know...
Continue ReadingAWS, advertising and automation (AI) are expected to deliver a boost for Amazon. Read more about AMZN stock's upcoming earnings...
Continue ReadingAllurion stock soars on weight-loss therapy update. Stardust Power breaks ground on Oklahoma lithium refinery. OpenAI launches shopping agent Operator; Etsy, eBay tick higher...
Continue Reading
In 2024, Deep Sail Capital Partners (the Fund) returned 38.1% net of fees while averaging 86% net long exposure. Click here to read the full fund letter...
Continue ReadingAmazon.com, Inc. delivered a strong set of numbers for 3Q24 driven by broad-based performance across all its segments. Learn more on AMZN stock here...
Continue ReadingFranklin Growth Fund underperformed its S&P 500 Index benchmark in the fourth quarter. US stocks collectively rose in the fourth quarter of 2024...
Continue ReadingIs Microsoft Corporation (MSFT) the Best Socially Responsible Stock to Buy According to Hedge Funds?
We recently compiled a list of the 8 Best Socially Responsible Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Microsoft Corporation (NASDAQ:MSFT) stands against other best socially responsible stocks to buy according to hedge funds. Socially responsible companies are businesses that integrate social and environmental […]...
Continue ReadingRead here for a financial analysis of Avride in the robotaxi market, potential investors, and implications for Nebius Group's valuation...
Continue ReadingWARREN, N.J., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Company” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T-cell therapeutics for infectious diseases and cancers, today announced key insights from its recent fireside chat during the J.P. Morgan Healthcare Conference. Utilizing artificial intelligence (AI) and machine learning (ML) has been critical for Tevogen Bio, given its core commit...
Continue Reading